Declomipramine en es it fr

Declomipramine Brand names, Declomipramine Analogs

Declomipramine Brand Names Mixture

  • No information avaliable

Declomipramine Chemical_Formula


Declomipramine RX_link

Declomipramine fda sheet

Declomipramine FDA

Declomipramine msds (material safety sheet)

Declomipramine Synthesis Reference

No information avaliable

Declomipramine Molecular Weight

280.407 g/mol

Declomipramine Melting Point

174.5 oC

Declomipramine H2O Solubility

18.2 mg/L

Declomipramine State


Declomipramine LogP


Declomipramine Dosage Forms


Declomipramine Indication

For the relief of symptoms of depression and as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older.

Declomipramine Pharmacology

Imipramine is a tricyclic antidepressant with general pharmacological properties similar to those of structurally related tricyclic antidepressant drugs such as amitriptyline and doxepin. A tertiary amine, imipramine inhibits the reuptake of serotonin more so than most secondary amine tricyclics, meaning that it blocks the reuptake of neurotransmitters serotonin and noradrenaline almost equally. It is also effective in migraine prophylaxis, but not in abortion of acute migraine attack.

Declomipramine Absorption

Rapidly and well absorbed after oral administration

Declomipramine side effects and Toxicity

Oral, rat LD50: 355 to 682 mg/kg. Toxic signs proceed progressively from depression, irregular respiration and ataxia to convulsions and death.

Declomipramine Patient Information

Declomipramine Organisms Affected

Humans and other mammals